## EL: Estee Lauder Companies, Inc. (T - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.1% in upper entry zone (4.0-10.0%), top 4% cross-sectional ranking. Short-term MRS_5 (3.3%) confirms momentum alignment. Strong momentum (+1.1% 5-day acceleration). Outperforming sector by 7.7%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($101.35)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Procter & Gamble Stock vs. Colgate-Palmolive Stock**
- Source: Trefis | 20251216T151357 | Neutral | Relevance: 64%
- This article compares Procter & Gamble (PG) stock with Colgate-Palmolive (CL) stock, asserting PG as the better investment due to stronger revenue growth, superior profitability, and more attractive valuation. The analysis highlights PG's higher operating margins and better revenue performance compared to CL, despite both stocks underperforming the S&P 500 year-to-date. The article also suggests diversified portfolio strategies for investors seeking lower volatility.

**2. What American Express CEO Just Said Should Get Dividend Investors Very Excited**
- Source: 24/7 Wall St. | 20251216T172009 | Neutral | Relevance: 60%
- American Express CEO Stephen Squeri's recent statements highlight the company's strong credit quality and affluent customer base, leading to lower write-off rates during economic downturns. This positions American Express as a compelling dividend growth stock with a proven track record of increasing dividends at an 11% compound annual growth rate over the past decade, making it a favorite of Warren Buffett, who maintains a significant stake in the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $110 | $105 | +5% |
| 2025-12-16 | Evercore ISI Gr | $125 | $115 | +9% |
| 2025-11-25 | Rothschild & Co | $70 | $83 | -16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |
| 2025-12-16 | Evercore ISI Gr | main | Outperform |
| 2025-11-25 | Rothschild & Co | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.04M) |
| Sells | 15 ($1015.95M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+0.0%)
- Blackrock Inc.: 7.2% (+0.6%)
- Capital World Invest: 5.2% (+0.1%)
- State Street Corpora: 4.7% (+2.4%)
- FMR, LLC: 4.7% (-30.2%)

### Key Risks

1. Heavy insider selling: $1016M sold (15 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.09 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +7%). Insider selling cluster ($1016.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.9B |
| Beta | 1.18 |
| 52W Range | $48.37 - $109.62 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.09 |
| Forward P/E | 36.9 |
| Current P/E | 50.0 |
| YoY Growth | 35.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 8.0% to 9.1% (+1.1% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 3.3% confirms short-term momentum alignment. AM_20 at 8.3% shows strong absolute momentum above own 20MA. Outperforming sector by 7.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.11% (CS: 96) | Strong |
| RSI_14 | 65.5 | Neutral |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.082x | Above |
| vs SMA50 | 1.121x | Above |
| vs SMA200 | 1.328x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $107.97
- **Stop Loss:** $101.35 (6.1% risk)
- **Target:** $117.90 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 107
- **Position Value:** $11,552.79
- **Portfolio %:** 11.55%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-05 (Est: $0.82)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.18 | $0.32 | +81.9% |
| 2025Q2 | $0.09 | $0.09 | +1.1% |
| 2025Q1 | $0.31 | $0.65 | +108.8% |
| 2024Q4 | $0.32 | $0.62 | +93.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*